Europe Mammography Market Size (2024 - 2029)

Europe Mammography Market Analysis

The Europe Mammography Market size is estimated at USD 594.29 million in 2024, and is expected to reach USD 906.03 million by 2029, growing at a CAGR of 8.80% during the forecast period (2024-2029).

The COVID-19 outbreak hurt the mammography market because many hospitals and screening centers had to close because of a lockdown.For example, the NCBI research study that came out in June 2022 says that COVID-19 has made people less likely to go to breast cancer screenings, especially those who have gone before and those who are new. Also, a study published by the British Journal of Cancer in March 2021 says that the COVID-19 pandemic in Europe messed up a lot of breast cancer screening programs, which led to an increase of 2.0 breast cancer deaths per 100,000 people in 10 years.This has impacted the market's growth. However, with the ease of COVID-19 restrictions, decreasing cases of COVID-19, and the resumption of screening services, hospital and clinic visits for screening breast cancer have increased, owing to which the market has slowly started to gain traction and is expected to maintain the upward trend over the forecast period.

The main things driving market growth are the growing number of women with breast cancer, improvements in breast imaging technology, and efforts to raise awareness about breast cancer screening.Breast cancer is one of the most common types of cancer in Europe. Because of this, there is a growing need for proper treatment and screening to find breast cancer, so the market is likely to grow over the next few years.For example, a report from the Joint Research Commission of the European Commission that came out in July 2021 said that breast cancer would be the most common type of cancer in Europe in 2021.The same source also reported that more than 355,000 women in the European Union (EU-27) were diagnosed with breast cancer in 2021, which was about 13.3% of all cancer diagnoses. Over the next five years, the market is also expected to grow because more people are learning about breast cancer and getting checked on time.For instance, as per a news article published in October 2021, a breast cancer awareness campaign, 'Breast Cancer Affects Us All', was created by Wefra Life and the non-profit association Pink Ribbon Germany to raise awareness about breast cancer, create a sense of community around the issue, and promote breast care through a free multilingual app that covers all relevant aspects of early breast cancer detection and prevention in multimedia form in seven different languages. Furthermore, in July 2021, Federación Espaola de Cancer de Mama (FECMA) organized a campaign to raise awareness about the types of breast cancer and the needs of breast cancer patients and advocate for them. Thus, increasing cases of breast cancer and favorable initiatives are expected to propel market growth over the forecast period.

Several companies are also working to improve breast cancer screening programs in Germany and to increase their market share in the country by forming strategic alliances, such as partnerships and acquisitions. For example, in July 2021, GE Healthcare Germany donated a mobile mammography unit to help check for breast cancer in women. Within three months, the unit was made for private radiology practice after training the users and calibrating the mammography equipment. Also, a lot of big tech companies use AI (artificial intelligence) models that can automatically find breast cancer. For instance, in May 2021, Roche Italia and Fujifilm Italia collaborated with the Italian National Health Services to reprioritize breast health with the screening-routine campaign. This collaboration included the replacement of obsolete equipment with a focus on the ratio between analog and digital machines in each region of Italy. These programs and technological advancements associated with mammograms are expected to boost market growth over the forecast period.

But the market may not grow as fast as expected over the next few years if the costs are high and insurance companies don't pay for them or if radiation exposure causes bad side effects.

Europe Mammography Industry Segmentation

According to the scope of the report, mammography is a standard diagnostic and screening method used to look for cancerous tumors in the breast tissue. The process involves the use of low-energy X-rays for the early detection of breast cancer. The Europe Mammography Market is Segmented by Product (Digital Systems, Analog Systems, Breast Tomosynthesis, and Other Products), End-User (Hospitals, Specialty Clinics, and Diagnostic Centers), and Geography (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe). The report offers the value (in USD million) for the above segments.